Exosome as a service for next-gen biological applications.

EaaS for next-gen biological applications.

Exosome as a service for next-gen biological applications.

Scalable, standardized manufacturing, for the exosome revolution.

Scalable, standardized manufacturing, for the exosome revolution.

Scalable, standardized manufacturing, for the exosome revolution.

Trusted by

Trusted by

Trusted by

Why Vesicly

Why Vesicly

Why Vesicly

The first exosome-dedicated CDMO in Latin America built for

The first exosome-dedicated CDMO in Latin America built for

The first exosome-dedicated CDMO in Latin America built for

cosmeceutic.

therapeutics.

biology applications.

cosmeceutic.

cosmeceutic.

therapeutics.

biology applications.

cosmeceutic.

cosmeceutic.

therapeutics.

biology applications.

cosmeceutic.

Hover over the cards to learn more.

Manufacturing Scalability

Proprietary technology

Capital-free service model

Americas-first advantage

Manufacturing Scalability

Proprietary technology

Capital-free service model

Americas-first advantage

Manufacturing Scalability

Proprietary technology

Capital-free service model

Americas-first advantage

Services

Services

Services

Exosome-as-a-service offerings

Exosome-as-a-service offerings

Exosome-as-a-service offerings

Hover over the cards to learn more.

Tap on the cards to learn more.

Exosome Vials

Ready-to-use, standardized RUO exosomes

Exosome Vials

Ready-to-use, standardized RUO exosomes

Exosome Vials

Ready-to-use, standardized RUO exosomes

Custom Isolation & Process Development

For biotechs needing proof-of-concept data

Custom Isolation & Process Development

For biotechs needing proof-of-concept data

Custom Isolation & Process Development

For biotechs needing proof-of-concept data

Custom Isolation & Process Development

For biotechs needing proof-of-concept data

GLP/GMP Manufacturing

Plan your future manufacturing needs

GLP/GMP Manufacturing

Ready-to-scale therapeutic developers

GLP/GMP Manufacturing

Ready-to-scale therapeutic developers

Wound-healing patches

The future of regenerative medicine & cosmeceutics

Wound-healing patches

The future of regenerative medicine & cosmeceutics

Wound-healing Patches

The future of regenerative medicine & cosmeceutics

Wound-healing Patches

The future of regenerative medicine & cosmeceutics

GLP/GMP Manufacturing

Ready-to-scale therapeutic developers

Wound-healing Patches

The future of regenerative medicine & cosmeceutics

Coming soon

Isolation Kits

Team

Team

Team

Connecting exosome science to

real-world impact

Connecting exosome science to

real-world impact

Connecting exosome science to

real-world impact

Tap on the cards to learn more.

Tap on the cards to learn more.

Tap on the cards to learn more.

Co-Founder & CEO

CARLOS

LUZZANI

Co-Founder & CEO

CARLOS

LUZZANI

Co-Founder & CEO

CARLOS

LUZZANI

Co-Founder & Scientific Lead

MIKELE AMONDARAIN

Co-Founder & Scientific Lead

MIKELE AMONDARAIN

Co-Founder & Scientific Lead

MIKELE AMONDARAIN

Trusted by

Trusted by

Trusted by

Contact Us

Contact Us

Contact Us

Ready to join the exosome revolution?

Ready to join the exosome revolution?

Ready to join the exosome revolution?

Reach out or book a call.

Reach out or book a call.

Reach out or book a call.

Copyright © 2025 Vesicly

All rights reserved.

Copyright © 2025 Vesicly

All rights reserved.

Copyright © 2025 Vesicly

All rights reserved.